Literature DB >> 7797593

Characterization of the murine mu opioid receptor gene.

D L Kaufman1, D E Keith, B Anton, J Tian, K Magendzo, D Newman, T H Tran, D S Lee, C Wen, Y R Xia.   

Abstract

The analgesic and addictive properties of morphine and other opioid drugs are thought to result from their interaction with mu opioid receptors. Using a delta opioid receptor cDNA as a probe, we have isolated a murine mu opioid receptor cDNA clone (mMOR). Stable expression of mMOR in Chinese hamster ovary cells conferred high binding affinity for mu receptor ligands including morphine and [D-Ala2,N-methyl-Phe4,Gly5-ol]-enkephalin and low affinity for delta and kappa preferring ligands. Treatment of these cell lines with morphine and other mu agonists inhibited forskolin-induced cAMP accumulation, demonstrating a functional coupling of mMOR to the inhibition of adenylate cyclase. The predicted amino acid sequence of mMOR shares approximately 55% overall amino acid identity with the delta receptor and approximately 97% identity with the recently reported rat mu opioid receptor. Expression of the mu receptor in mouse brain as revealed by in situ hybridization parallels the reported pattern of distribution of mu-selective ligand binding sites. Chromosomal localization (to mouse chromosome 10) and Southern analysis are consistent with a single mu opioid receptor gene in the mouse genome, suggesting that the various pharmacologically distinct forms of the mu receptor arise from alternative splicing, post-translational events, or from a highly divergent gene(s).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797593     DOI: 10.1074/jbc.270.26.15877

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.

Authors:  M Narita; H Mizoguchi; M Narita; H Nagase; T Suzuki; L F Tseng
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  Neurotrophin-regulated sorting of opioid receptors in the biosynthetic pathway of neurosecretory cells.

Authors:  Kyung-Ah Kim; Mark von Zastrow
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

Review 3.  Transcriptional and epigenetic regulation of opioid receptor genes: present and future.

Authors:  Li-Na Wei; Horace H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

Review 4.  Advances in opioid pharmacology.

Authors:  Geoffrey K Gourlay
Journal:  Support Care Cancer       Date:  2004-12-21       Impact factor: 3.603

Review 5.  Mu opioids and their receptors: evolution of a concept.

Authors:  Gavril W Pasternak; Ying-Xian Pan
Journal:  Pharmacol Rev       Date:  2013-09-27       Impact factor: 25.468

Review 6.  Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides.

Authors:  B L Kieffer
Journal:  Cell Mol Neurobiol       Date:  1995-12       Impact factor: 5.046

Review 7.  Functional analysis of cloned opioid receptors in transfected cell lines.

Authors:  E T Piros; T G Hales; C J Evans
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

8.  Activation of μ-opioid receptors in the dorsal striatum is necessary for adult social attachment in monogamous prairie voles.

Authors:  James P Burkett; Lauren L Spiegel; Kiyoshi Inoue; Anne Z Murphy; Larry J Young
Journal:  Neuropsychopharmacology       Date:  2011-07-06       Impact factor: 7.853

Review 9.  The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses.

Authors:  G R Uhl; I Sora; Z Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

10.  The untranslated region of (mu)-opioid receptor mRNA contributes to reduced opioid sensitivity in CXBK mice.

Authors:  K Ikeda; T Kobayashi; T Ichikawa; T Kumanishi; H Niki; R Yano
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.